Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups
Annals of Hematology · 24.03.2026 · 105 (4)
DOI: 10.1007/s00277-026-06956-8 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Hematology, online erschienen am 24.03.2026. Verfasst von Cristina Rivera-Pérez und 19 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Transplant Department, Pediatric Cancer Center Barcelona (PCCB) - Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Antigens, CD1. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundació Institució dels Centres de Recerca de Catalunya.
Abstract (Originalsprache)
Patients with relapsed/refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) have very poor prognosis. CAR T-cell therapy is being explored in these patients with encouraging results. Specifically, CD1a-directed CAR T-cells are being explored in clinical trials to treat cortical T-ALL (CD1a+), but there are no data on outcome in this subgroup of patients before this therapy. This retrospective, observational study aimed to describe the characteristics and outcomes of patients with R/R CD1a + T-ALL. We included pediatric and adult patients diagnosed with R/R CD1a + T-ALL in 25 sites of Spain between March 2006 and May 2022. The primary outcome of the study was overall survival (OS). Forty-three patients, 28 adults and 15 children, with R/R CD1a + T-ALL were included. Median (range) age at inclusion was 24 years (5–57), and 82.5% were male. After a median (range) follow-up of 7.0 years (5.1–13.6), 6 (14.0%) patients were alive and in complete remission (CR) and 37 (86.0%) had died. Five-year OS was 16% (95% CI; 7–29%). Bone marrow relapse, an interval < 12 months between first CR and relapse, and lack of allogeneic hematopoietic stem cell transplantation during salvage treatment were associated with worse OS. Our results confirm that patients with R/R CD1a + T-ALL have a very poor prognosis, highlighting the need for new treatment alternatives in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cell Transplant Department, Pediatric Cancer Center Barcelona (PCCB) - Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
- Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.
- Clinical Hematology Department, Institut Català d'Oncologia - Hospital Germans Trias i Pujol, Badalona, Spain.
- Leukemia and Lymphoma Department, Pediatric Cancer Center Barcelona (PCCB) - Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
- Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
- Hematology Department, Hospital Universitari i Politècnic La Fe, València, Spain.
Förderung
- Fundació Institució dels Centres de Recerca de Catalunya
Zitieren
APA
Rivera-Pérez, C., Morgades, M., Alonso-Saladrigues, A., Montesinos, P., Murciano, T., Gil, C., Adán, R., Esteve, J., Fuentes, C., Amigo, M. L., González-Martínez, B., Coll, R., Dapena, J. L., de Llano, M. P. Q., Fuster, J. L., García-Cadenas, I., Tasso, M., Barba, P., Rives, S., & Ribera, J. M. (2026). Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups. Annals of Hematology, 105(4). https://doi.org/10.1007/s00277-026-06956-8
Vancouver
Rivera-Pérez C, Morgades M, Alonso-Saladrigues A, Montesinos P, Murciano T, Gil C, et al. Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups. Annals of Hematology. 2026;105(4). doi:10.1007/s00277-026-06956-8
BibTeX
@article{RiveraPrez2026,
author = {Rivera-Pérez, Cristina and Morgades, Mireia and Alonso-Saladrigues, Anna and Montesinos, Pau and Murciano, Thais and Gil, Cristina and Adán, Rosa and Esteve, Jordi and Fuentes, Carolina and Amigo, María Luz and González-Martínez, Berta and Coll, Rosa and Dapena, José Luis and de Llano, María Paz Queipo and Fuster, José Luis and García-Cadenas, Irene and Tasso, María and Barba, Pere and Rives, Susana and Ribera, Josep Maria},
title = {Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {4},
doi = {10.1007/s00277-026-06956-8}
}
EUVIMED